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Abstract
Aim: We aimed to define reference ranges for right ventricular (RV) volumes, ejection fraction (EF) in thalassemia major 
patients (TM) without myocardial iron overload.
Methods and results: RV volumes, EF and mass were measured in 80 TM patients who had no myocardial iron 
overload (myocardial T2* > 20 ms by cardiovascular magnetic resonance). All patients were receiving deferoxamine 
chelation and none had evidence of pulmonary hypertension or other cardiovascular comorbidity. Forty age and sex 
matched healthy non-anemic volunteers acted as controls. The mean RV EF was higher in TM patients than controls 
(males 66.2 ± 4.1% vs 61.6 ± 6%, p = 0.0009; females 66.3 ± 5.1% vs 62.6 ± 6.4%, p = 0.017), which yielded a raised lower 
threshold of normality for RV EF in TM patients (males 58.0% vs 50.0% and females 56.4% vs 50.1%). RV end-diastolic 
volume index was higher in male TM patients (mean 98.1 ± 17.3 mL vs 88.4 ± 11.2 mL/m2, p = 0.027), with a higher 
upper limit (132 vs 110 mL/m2) but this difference was of borderline significance for females (mean 86.5 ± 13.6 mL vs 
80.3 ± 12.8 mL/m2, p = 0.09, with upper limit of 113 vs 105 mL/m2). The cardiac index was raised in TM patients (males 
4.8 ± 1.0 L/min vs 3.4 ± 0.7 L/min, p < 0.0001; females 4.5 ± 0.8 L/min vs 3.2 ± 0.8 L/min, p < 0.0001). No differences in 
RV mass index were identified.
Conclusion: The normal ranges for functional RV parameters in TM patients with no evidence of myocardial iron 
overload differ from healthy non-anemic controls. The new reference RV ranges are important for determining the 
functional effects of myocardial iron overload in TM patients.
Introduction
Patients with beta-thalassemia major (TM) have a severe
hereditary anemia which requires lifelong transfusions to
prolong survival and allow normal development [1]. Due
to the absence of an effective physiological excretory
pathway in humans, the unwanted consequence of these
blood transfusions is iron overload, predominantly affect-
ing the heart, liver and endocrine organs. Despite recent
improvements in patient care, iron overload cardiomyo-
pathy remains a leading cause of death in TM patients in
many centers [2,3]. The early detection of iron-induced
cardiac toxicity therefore forms a key component of clini-
cal management. The assessment of cardiac iron loading
can be performed directly by measurement of myocardial
T2* (explicit myocardial iron assessment) or indirectly by
the assessment of ventricular volumes and function
(examination of effects of myocardial iron on cardiac
function).
Previously published data have shown that indices of
the left ventricle (LV) such as volumes and ejection frac-
tion (EF) differ in non-cardiac iron loaded TM patients
from healthy non-anemic controls, most likely due to
chronically increased cardiac output related to the ane-
mia [4,5]. These differences in the normal range of
expected values affect the interpretation of measures of
ventricular function from echocardiography and cardio-
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vascular magnetic resonance (CMR). This is important
with regard to the early detection of impaired EF because
the use of inappropriate reference values may mask the
diagnosis of underlying iron-overload cardiomyopathy
and this can result in delayed treatment or a preventable
episode of heart failure, which places the patient at high
hazard [6]. Conversely, an apparently dilated heart in a
TM patient may be within normal limits for the non-iron
overloaded TM population. Although it has been shown
that both RV and LV EF are reduced by iron loading [7,8],
the normal ranges for RV parameters and function in TM
patients who have no evidence of cardiac iron loading are
unknown. The aim of this study therefore was to define
the normal reference ranges for RV volumes, ejection
fraction and mass in non-iron overloaded transfusion
dependent TM patients in comparison with non-anemic
healthy controls. CMR was used for this assessment as it
is regarded as the gold-standard technique for measure-
ment of both LV and RV volumes and function [9-11],
and CMR can also measure myocardial iron loading using
myocardial T2*.
Methods
Study population
We performed a retrospective analysis of patients with
beta-thalassemia major who were referred for their first-
myocardial T2* scan from 21 UK hematology centres. All
patients were regularly transfused (every 3-4 weeks) to
maintain pre-transfusion hemoglobin levels of 9-10 g/dl
and all had received iron chelation therapy from an early
age or from the mid-to-late 1970s if born before this time.
To remove any possible effects of different iron chelating
agents, only patients taking deferoxamine as a single iron
chelator were included. None of the patients had received
treatment with either of the oral chelating agents (defer-
iprone or deferasirox). Forty male and forty female
patients over the age of 18 years who had no myocardial
iron loading (defined as having cardiac T2* > 20 ms) and
no history of any known cardiovascular pathology were
identified from the initial target population of 323
patients. The cut-off value for normal T2* was based on
the lower limit of normal observed in a cohort of healthy
volunteers [7]. Patients with evidence of pulmonary
hypertension (defined as tricuspid regurgitant velocity >
3.0 m/s at rest by transthoracic echocardiography) were
excluded. Forty age and sex matched healthy non-anemic
volunteers formed a control population for comparison.
All control subjects were healthy, asymptomatic volun-
teers with no cardiovascular risk factors or history of car-
diac disease. Each had a normal 12 lead
electrocardiogram and no abnormal signs on physical
examination. This study was approved by the local NHS
Research Ethics Committee. Written informed consent
was obtained from all of the volunteers. For the TM
patients, the Ethics Committee granted permission for
review of clinical and scan data, waiver of informed con-
sent and anonymous publication.
Cardiovascular magnetic resonance
All scans were performed using a 1.5T Sonata scanner
(Siemens Medical Systems, Erlangen, Germany). After
routine localizer images, each scan comprised of a contig-
uous set of breath-hold steady state free precession
(SSFP) short-axis cines at 10 mm intervals from base to
apex (7 mm slice thickness with 3 mm gap) using stan-
dardised techniques [5,12]. An ECG gated breath-hold
bright blood multi-echo sequence was also used to
acquire a single short axis mid-ventricular slice for the
measurement of myocardial T2* (a gradient echo
sequence acquired immediately after the R-wave trigger
with flip angle of 35°, matrix of 128 × 256 pixels, field of
view (FOV) 40 cm, bandwidth of 810 Hz per pixel and
repetition time (TR) of 20 ms between each radiofre-
quency (RF) pulse). This sequence generated a series of
images with a range of equally spaced echo times (TE =
2.6-16.7 ms) [13].
CMR analysis
Right ventricular volumes and mass were measured from
the SSFP cines as previously described [12,14], using
CMRtools (Cardiovascular Imaging Solutions, London).
This involved tracing the endocardial and epicardial bor-
ders at end-diastole and end-systole with semi-auto-
mated thresholding to delineate the blood pool (figure 1).
R V  t r a b e c u l a t i o n s  w e r e  e x c l u d e d  f r o m  t h e  b l o o d  p o o l
volume but included in the RV mass calculation. The tri-
cuspid valve plane was tracked in both systole and dias-
tole to ensure that any blood signal from the right atrium
was excluded from the ventricular volume calculation.
Any of the blood pool signal above the pulmonary valve
was also excluded from the ventricular volume using the
endocardial contour definitions. Cardiac output was cal-
culated from the product of right ventricular stroke vol-
ume and the mean heart rate recorded at the time of the
CMR scan. RV parameters were indexed to body surface
area (BSA) which was derived using the Mosteller for-
mula [12,15]. Myocardial T2* was measured from a single
full thickness region of interest in the septum of the mid-
ventricular slice using semi-automated software (Thalas-
semia-tools, Cardiovascular Imaging Solutions, London,
UK). For the analysis of T2*, mean signal intensity was
plotted against the echo time for each image in the series.
The T2* value was calculated as previously described
from the resulting exponential decay curve after truncat-
ing the curve to correct for background noise [16].
Hemoglobin measurements
Pre-transfusion hemoglobin measurements were com-
pared with right ventricular parameters. Where the inter-Carpenter et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:24
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val between the hemoglobin measurement and the index
CMR scan exceeded 1 week, patients were excluded from
this part of the analysis.
Statistical analysis
All continuous parameters were found to be normally
distributed and are therefore presented as mean ± stan-
dard deviation (SD). An unpaired two-tailed t-test was
used to compare TM patients with the healthy non-ane-
mic volunteers. Separate analysis was performed for
males and females due to known gender-specific differ-
ences for left and right ventricular parameters. Pearson
correlation was used to compare hemoglobin measure-
ments with the RV volumes and function measurements.
Statistical significance was set at p < 0.05. All statistical
analysis was performed using Stata 10.1 software (Stata-
Corp, Texas, USA).
Results
Patient population
A summary of the demographics for the patients and the
control population is given in table 1. Both groups were
well matched for age and sex. The body mass index was
equivalent in females but was slightly higher in the male
control population than the TM patients. However, both
male and female TM patients had significantly lower
weight, height and body surface area than the non-ane-
mic controls. Resting heart rate in TM patients was also
significantly higher than in the healthy controls.
Right ventricular parameters
The right ventricular parameters are detailed in table 2,
and represented graphically in figures 2 and 3. The mean
and upper limit of end-diastolic RV volume were higher
in TM patients than controls for males, but this was bor-
derline significant for females (p = 0.027 for males, p =
0.093 for females). RV stroke volume and RV ejection
fraction were higher in TM patients for both males (p =
0.0015 for stroke volume, p = 0.0009 for RV EF) and
females (p = 0.0030 for stroke volume, p = 0.017 for RV
EF). The lower limit of RV EF was higher in TM patients
(males 58.0% vs 50.0%, females 56.4% vs 50.1%). The car-
diac output was higher in the TM cohort than controls (p
= 0.014 for males, p = 0.0033 for females) and this finding
was confirmed when cardiac output was indexed for BSA
(cardiac index, p < 0.0001). No significant difference was
found however between TM patients and controls for
either RV end-systolic volume index or RV mass index (p
= 0.11 to 0.77).
Correlation with hemoglobin levels
Hemoglobin results which coincided with CMR scans
(blood tests within one week of the scan) were obtained
in 59% of the patients investigated. There was no differ-
ence in any of the RV parameters between those patients
Figure 1 Calculation of RV parameters. Delineation of right ventric-
ular endocardial and epicardial borders using semi-automated soft-
ware, and summing up over all contiguous slices covering the right 
ventricle allows the calculation of all volume, mass and functional pa-
rameters. Representative images are shown for end-diastole and end-
systole together with tricuspid valve plane tracking (indicated by the 
yellow line on the four-chamber view). The RV blood pool is shown in 
blue, the LV blood pool in orange and the myocardium in beige.Carpenter et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:24
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with hemoglobin results and those in whom the results
were unavailable. Mean hemoglobin level was 9.7 ± 1.8 g/
dL for males (n = 20) and 10.5 ± 1.4 g/dL for females (n =
27). In the female TM patients, no significant correlations
existed between hemoglobin concentration and any of
the RV parameters. In male TM patients, an inverse cor-
relation was found between cardiac index and hemoglo-
bin (r = -0.47, p = 0.04). No other significant correlation
was found.
Discussion
Cardiac complications due to myocardial siderosis
remain a serious problem for TM patients. Until recently,
more than 50% of TM patients died before the age of 35
from cardiac failure [17]. The monitoring of cardiac iron
using T2* CMR has had a major impact on saving the
lives of patients by identifying cardiac iron overload prior
to the occurrence of heart failure which therefore allows
tailored cardiac chelation [3]. However, cardiac T2* is not
available in all centers and non-cardiac measures of iron
loading are not satisfactory for assessing the risk of heart
failure in comparison with cardiac T2* [18]. An indirect
approach to assessment of cardiac iron loading is to mea-
sure cardiac volumes and function. Although the litera-
ture establishing the value of this approach is rather
sparse [19], it has the merit that techniques for assess-
ment of cardiac function such as echocardiography are
widely available and its application is included in some
clinical guidelines [20]. In favor of the use of functional
heart measurements is the clear evidence of a correlation
with cardiac iron loading that is not present for cross-sec-
tional measures of blood iron (ferritin) or liver iron [7].
Any such approach however, requires that normal values
for TM patients who do not have cardiac iron loading are
established. Previous data has shown that left ventricular
volumes and function in non-cardiac iron loaded TM
patients are significantly different from healthy non-ane-
mic controls [4], but there is no data on the normal values
of RV volumes and function in non-cardiac iron loaded
patients with TM. The right ventricle has consistently
been underestimated as an important factor in heart dis-
ease and its power to predict adverse cardiac outcomes,
which is independent and additional to LV function, has
often been overlooked in the past. The balance has been
addressed in a number of relatively recent studies of the
RV in association with outcomes in heart failure syn-
dromes related to dilated cardiomyopathy [21], chronic
systolic dysfunction [22], and ischemia [23-25], and also
in patients with congenital heart disease [26-28]. This
suggests that RV function may be a significant contribu-
tor to the clinical manifestation of heart failure seen in
myocardial iron overload. Therefore in this study, we
evaluated RV parameters using CMR in a population of
r e g u l a r l y  t r a n s f u s e d  T M  p a t i e n t s  w i t h  n o  c a r d i a c  i r o n
loading or pulmonary hypertension or other cardiac mor-
bidity and have compared the findings to those of healthy
non-anemic subjects to established reference ranges that
would prove useful to assess the functional effects on the
Table 1: Demographics for TM patients and controls.
TM patients
Mean ± SD
Controls
Mean ± SD
P value
Males
Age (years) 30 ± 8 30 ± 5 0.94
Height (m) 1.65 ± 0.1 1.80 ± 0.09 <0.0001
Weight (kg) 59.1 ± 8.9 75.8 ± 9.9 <0.0001
BMI (kg/m2) 21.9 ± 3.1 23.6 ± 3.1 0.048
BSA (m2) 1.64 ± 0.16 1.94 ± 0.15 <0.0001
Heart rate (min-1) 72.7 ± 10.4 64.0 ± 9.5 0.0024
Females
Age (years) 30 ± 8 30 ± 5 0.88
Height (m) 1.54 ± 8.9 1.67 ± 9.2 <0.0001
Weight (kg) 53.3 ± 10.1 61.4 ± 11.3 0.0064
BMI (kg/m2) 22.5 ± 4.5 22.0 ± 2.8 0.68
BSA (m2) 1.50 ± 0.15 1.68 ± 0.18 0.0001
Heart rate (min-1) 78.8 ± 10.1 64.8 ± 13.6 <0.0001
BSA -- body surface area, BMI -- body mass index.Carpenter et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:24
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heart of iron overload. Many TM patients have growth
retardation with short stature and low body weight. The
direct comparison of raw RV indices between TM
patients and a cohort of healthy non-anemic subjects
therefore requires indexing the RV volumes to body sur-
face area.
Our results show that compared with healthy non-ane-
mic controls, TM patients have a higher RV stroke vol-
ume and heart rate, which results in a higher cardiac
output. The RV EF is also increased mainly as a result of
an increased end-diastolic volume. These results are sim-
ilar to the observations of LV parameters in TM but the
d i f f e r e n c e s  i n  R V  p a r a m e t e r s  a p p e a r  t o  b e  l e s s  p r o -
nounced than those found for the LV [4]. Our results
stress that if functional measurements of the heart are to
be made and used clinically to indirectly assess cardiac
iron loading, then it is vital to use reference ranges from
TM patients with no cardiac iron loading as presented
from this study in order to prevent underdiagnosis of car-
diac siderosis when using the EF, or its overdiagnosis
when using the end-diastolic volume.
No correlation between hemoglobin level and RV
parameters was identified in female TM patients but in
males, there was an inverse correlation between hemo-
globin and cardiac index. It is not evident why male and
female patients differ but the result mirrors previous
observations [4]. An inverse relationship between hemo-
globin and cardiac index is predictable, and indicates a
higher output state with a greater degree of anemia.
There was no correlation between hemoglobin and RV
EF for either sex, a finding supported by a previous study
which found no difference in LV EF using radionuclide
ventriculography both before and 24 hours after blood
transfusion [19]. Pulmonary hypertension (which may
depress RV function and cause right heart failure) has
been described in thalassemia patients but although it is
prominent in those with thalassemia intermedia, it is
uncommon in well treated TM patients [29-31]. Not only
have we purposely excluded patients with pulmonary
hypertension from this study, but we also found no signif-
icant difference in RV mass between cases and controls, a
sensitive and specific measure for the diagnosis of pulmo-
nary hypertension using CMR [32]. Therefore we believe
there is no confounding of our results from pulmonary
hypertension.
Figure 2 Right ventricular volumes and ejection fraction in male 
TM patients and controls. RVEDVI = right ventricular end-diastolic 
volume index, RVESVI = right ventricular end-systolic volume index, 
RVSVI = right ventricular stroke volume index, RVEF = right ventricular 
ejection fraction, RVMI = right ventricular mass index.
Figure 3 Right ventricular volumes and ejection fraction in fe-
male TM patients and controls. RVEDVI = right ventricular end-dia-
stolic volume index, RVESVI = right ventricular end-systolic volume 
index, RVSVI = right ventricular stroke volume index, RVEF = right ven-
tricular ejection fraction, RVMI = right ventricular mass index.Carpenter et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:24
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The right ventricle has a complex anatomical structure
in comparison to the LV. Whereas the LV is approxi-
mately circular in cross-section, the RV is crescentic,
wrapping around the LV with separate inflow and outflow
portions, the tricuspid and the pulmonary valves being
physically separated by a muscular subpulmonary
infundibulum. The RV is thin walled with many trabecu-
lations and there is a moderator band of myocardial tis-
sue towards the apex. All of these features create
challenges for modeling RV volumes, making it more dif-
ficult to perform reliable measurements using standard
echocardiographic techniques. CMR is able to overcome
most of these issues and is currently considered the gold
standard for the measurement of cardiac volumes and
function [9], with well defined normalized values for the
RV [12]. The relative accuracy of echocardiography in
relation to CMR must therefore be considered when
interpreting results of RV measurements in clinical prac-
tice.
There is previously published data regarding RV func-
tion in patients with established heart failure due to myo-
cardial siderosis and other studies have reported RV
parameters in TM patients across a wide range of iron
loading [33-35]. However, our study focuses only on RV
Table 2: Right ventricular parameters for males and females.
TM patients
(mean ± SD)
[95% CI]
Controls
(mean ± SD)
[95% CI]
P value
Males
RVEDVI (mL/m2) 98.1 ± 17.3
[64.2 -- 132.0]
88.4 ± 11.2
[66.5 -- 110.4]
0.027
RVESVI (mL/m2) 33.2 ± 8.0
[17.5 -- 48.8]
33.8 ± 5.0
[24.0 -- 43.7]
0.77
RVSVI (mL/m2) 64.7 ± 11.2
[42.7 -- 86.6]
54.7 ± 10.3
[34.6 -- 74.8]
0.0015
RVEF (%) 66.2 ± 4.1
[58.0 -- 74.3]
61.6 ± 6.0
[50.0 -- 73.3]
0.0009
RVMI (g/m2) 38.8 ± 7.9
[23.3 -- 54.4]
36.4 ± 7.8
[21.1 -- 51.7]
0.27
CO (L/min) 7.9 ± 1.9
[4.16 -- 11.5]
6.6 ± 1.6
[3.4 -- 9.8]
0.014
CI (L/min/m2)4 . 8  ±  1 . 0
[2.9 -- 6.7]
3.4 ± 0.7
[2.0 -- 4.8]
<0.0001
Females
RVEDVI (mL/m2) 86.5 ± 13.6
[59.8 -- 113.2]
80.3 ± 12.8
[55.3 -- 105.3]
0.093
RVESVI (mL/m2) 29.2 ± 7.2
[15.1 -- 43.2]
30.3 ± 8.6
[13.5 -- 47.1]
0.58
RVSVI (mL/m2) 57.4 ± 9.2
[39.4 -- 75.5]
50.0 ± 7.8
[34.7 -- 65.2]
0.0030
RVEF (%) 66.3 ± 5.1
[56.4 -- 76.2]
62.6 ± 6.4
[50.1 -- 75.0]
0.017
RVMI (g/m2) 34.0 ± 7.7
[18.8 -- 49.1]
30.8 ± 5.3
[20.5 -- 41.1]
0.11
CO (L/min) 6.8 ± 1.7
[3.5 -- 10.1]
5.5 ± 1.5
[2.5 -- 8.4]
0.0033
CI (L/min/m2)4 . 5  ±  0 . 8
[2.9 -- 6.2]
3.2 ± 0.8
[1.7 -- 4.8]
<0.0001
All values are quoted as mean ± SD with 95% confidence intervals in square brackets. The table is divided into TM patients with no evidence 
of cardiac iron overload and age-matched healthy controls.
RVEDVI = right ventricular end-diastolic volume index, RVESVI = right ventricular end-systolic volume index, RVSVI = right ventricular stroke 
volume index, RVEF = right ventricular ejection fraction, RVMI = right ventricular mass index, CO = cardiac output, CI = cardiac indexCarpenter et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:24
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volumes and function in TM patients without evidence of
cardiac iron loading.
Limitations
We have restricted our investigation to CMR parameters
of RV function and comparisons with RV measurements
from other imaging modalities should be interpreted with
caution. While RV EF is the most widely available method
for assessing RV function, it may not adequately reflect
RV contractility and other techniques for the assessment
of the RV may provide additional insights. For the hemo-
globin correlation, we only used results in a subset of the
patients for which the time between the CMR scan and
the hemoglobin estimation was less than 1 week. Subset
analysis showed no significant differences in any of the
RV parameters between patients with and those without
hemoglobin results. We did not have reliable information
regarding the date of the most recent transfusion prior to
the CMR assessment in the TM cohort. While transfu-
sion could potentially affect RV parameters including RV
EF, there is only limited data regarding the effects of
transfusion on ventricular function. For the LV, no signif-
icant difference in LV EF is observed between measure-
ments taken before or 24 hours after blood transfusion
[19].
Conclusion
Our findings show that the normal ranges for RV param-
eters differ between TM patients without cardiac iron
loading and normal, non-anemic controls. The lower
limit of RVEF in TM patients without cardiac iron load-
ing is significantly higher than the lower limit of the nor-
mal range in controls which could lead to under-
diagnosis of iron-loading cardiomyopathy if this is not
appreciated. It is important to use reference ranges which
are specific to non-cardiac iron loaded TM patients when
assessing cardiac volumes and function as a surrogate for
cardiac iron loading.
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